387 related articles for article (PubMed ID: 22213684)
1. Development of liquid chromatography-tandem mass spectrometry-based analytical assays for the determination of HIF stabilizers in preventive doping research.
Beuck S; Bornatsch W; Lagojda A; Schänzer W; Thevis M
Drug Test Anal; 2011; 3(11-12):756-70. PubMed ID: 22213684
[TBL] [Abstract][Full Text] [Related]
2. Detection by LC-MS/MS of HIF stabilizer FG-4592 used as a new doping agent: Investigation on a positive case.
Buisson C; Marchand A; Bailloux I; Lahaussois A; Martin L; Molina A
J Pharm Biomed Anal; 2016 Mar; 121():181-187. PubMed ID: 26808067
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometric characterization of a prolyl hydroxylase inhibitor GSK1278863, its bishydroxylated metabolite, and its implementation into routine doping controls.
Thevis M; Milosovich S; Licea-Perez H; Knecht D; Cavalier T; Schänzer W
Drug Test Anal; 2016 Aug; 8(8):858-63. PubMed ID: 26361079
[TBL] [Abstract][Full Text] [Related]
4. Identification of Hypoxia-inducible factor (HIF) stabilizer roxadustat and its possible metabolites in thoroughbred horses for doping control.
Mathew B; Philip M; Perwad Z; Karatt TK; Caveney MR; Subhahar MB; Karakka Kal AK
Drug Test Anal; 2021 Jun; 13(6):1203-1215. PubMed ID: 33569900
[TBL] [Abstract][Full Text] [Related]
5. Screening for benfluorex and its major urinary metabolites in routine doping controls.
Thevis M; Sigmund G; Gougoulidis V; Beuck S; Schlörer N; Thomas A; Kwiatkowska D; Pokrywka A; Schänzer W
Anal Bioanal Chem; 2011 Aug; 401(2):543-51. PubMed ID: 21116611
[TBL] [Abstract][Full Text] [Related]
6. Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesised reference material for the support of LC-MS/MS-based drug testing.
Beuck S; Möller I; Thomas A; Klose A; Schlörer N; Schänzer W; Thevis M
Anal Bioanal Chem; 2011 Aug; 401(2):493-505. PubMed ID: 21455647
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometric characterization of the hypoxia-inducible factor (HIF) stabilizer drug candidate BAY 85-3934 (molidustat) and its glucuronidated metabolite BAY-348, and their implementation into routine doping controls.
Dib J; Mongongu C; Buisson C; Molina A; Schänzer W; Thuss U; Thevis M
Drug Test Anal; 2017 Jan; 9(1):61-67. PubMed ID: 27346747
[TBL] [Abstract][Full Text] [Related]
8. Metabolic studies of hypoxia-inducible factor stabilisers IOX2, IOX3 and IOX4 (in vitro) for doping control.
Philip M; Mathew B; Karatt TK; Perwad Z; Subhahar MB; Karakka Kal AK
Drug Test Anal; 2021 Apr; 13(4):794-816. PubMed ID: 33458935
[TBL] [Abstract][Full Text] [Related]
9. Applications and challenges in using LC-MS/MS assays for quantitative doping analysis.
Wang Z; Lu J; Zhang Y; Tian Y; Yuan H; Xu Y
Bioanalysis; 2016 Jun; 8(12):1307-22. PubMed ID: 27241820
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor stabilizers and other small-molecule erythropoiesis-stimulating agents in current and preventive doping analysis.
Beuck S; Schänzer W; Thevis M
Drug Test Anal; 2012 Nov; 4(11):830-45. PubMed ID: 22362605
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of urinary prenylamine metabolites by means of liquid chromatography-tandem mass spectrometry.
Beuck S; Sigmund G; Koch A; Schänzer W; Pokrywka A; Kwiatkowska D; Thevis M
Drug Test Anal; 2012 Sep; 4(9):701-16. PubMed ID: 22786790
[TBL] [Abstract][Full Text] [Related]
12. Expanding analytical possibilities concerning the detection of stanozolol misuse by means of high resolution/high accuracy mass spectrometric detection of stanozolol glucuronides in human sports drug testing.
Schänzer W; Guddat S; Thomas A; Opfermann G; Geyer H; Thevis M
Drug Test Anal; 2013; 5(11-12):810-8. PubMed ID: 23873860
[TBL] [Abstract][Full Text] [Related]
13. Unusual mass spectrometric dissociation pathway of protonated isoquinoline-3-carboxamides due to multiple reversible water adduct formation in the gas phase.
Beuck S; Schwabe T; Grimme S; Schlörer N; Kamber M; Schänzer W; Thevis M
J Am Soc Mass Spectrom; 2009 Nov; 20(11):2034-48. PubMed ID: 19734057
[TBL] [Abstract][Full Text] [Related]
14. Simplifying and expanding analytical capabilities for various classes of doping agents by means of direct urine injection high performance liquid chromatography high resolution/high accuracy mass spectrometry.
Görgens C; Guddat S; Thomas A; Wachsmuth P; Orlovius AK; Sigmund G; Thevis M; Schänzer W
J Pharm Biomed Anal; 2016 Nov; 131():482-496. PubMed ID: 27693991
[TBL] [Abstract][Full Text] [Related]
15. Detection of new exemestane metabolites by liquid chromatography interfaced to electrospray-tandem mass spectrometry.
de Albuquerque Cavalcanti G; Carius Garrido B; Dias Leal F; Costa Padilha M; Mazzarino M; de la Torre X; Botre F; Radler de Aquino Neto F
J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):248-54. PubMed ID: 21924357
[TBL] [Abstract][Full Text] [Related]
16. Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls.
Möller I; Wintermeyer A; Bender K; Jübner M; Thomas A; Krug O; Schänzer W; Thevis M
Drug Test Anal; 2011 Sep; 3(9):609-20. PubMed ID: 20872894
[TBL] [Abstract][Full Text] [Related]
17. Analysis of anabolic androgenic steroids as sulfate conjugates using high performance liquid chromatography coupled to tandem mass spectrometry.
Rzeppa S; Heinrich G; Hemmersbach P
Drug Test Anal; 2015; 7(11-12):1030-9. PubMed ID: 26472592
[TBL] [Abstract][Full Text] [Related]
18. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
Gosetti F; Mazzucco E; Gennaro MC; Marengo E
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
[TBL] [Abstract][Full Text] [Related]
19. High-throughput screening for various classes of doping agents using a new 'dilute-and-shoot' liquid chromatography-tandem mass spectrometry multi-target approach.
Guddat S; Solymos E; Orlovius A; Thomas A; Sigmund G; Geyer H; Thevis M; Schänzer W
Drug Test Anal; 2011; 3(11-12):836-50. PubMed ID: 22135086
[TBL] [Abstract][Full Text] [Related]
20. In vitro metabolism studies on the selective androgen receptor modulator (SARM) LG121071 and its implementation into human doping controls using liquid chromatography-mass spectrometry.
Knoop A; Krug O; Vincenti M; Schänzer W; Thevis M
Eur J Mass Spectrom (Chichester); 2015; 21(1):27-36. PubMed ID: 25906032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
